TRUPANION, INC. Q4 FY2024 earnings call

Management Statement and Operational Highlights

• 2024 Highlights: Subscription revenue grew 20% year-over-year, achieved industry-leading 71% value proposition for the second consecutive quarter, with the highest quarterly subscription adjusted operating margin in history. Adjusted operating income grew nearly 40% to a record $114 million for the full year 2024, and free cash flow was $39 million, an all-time high. Reached a milestone of protecting over 1 million cats and dogs, with ~257,000 added in the last 12 months. Surpassed $3 billion in paid veterinary invoices. Made progress in remediating material weaknesses identified in the 2023 audit.
• 2025 Plans: Anticipate steady, sustainable growth in subscription business with margin expansion and rate changes normalizing. Will step up pet acquisition investment, with the majority of dollars reinvested in growing the core Trupanion brand in North America. Commit to ongoing investment in systems and infrastructure, including retiring legacy platforms and strengthening control framework. Expect to build on new technology to elevate member experience.

Segment Performance

• Subscription Business: Fourth quarter subscription revenue was $227.8 million, up 19% year-over-year. Subscription adjusted operating income was $35 million, an increase of 40% from the prior year, with a subscription adjusted operating margin of 15.3% of subscription revenue, up from 13% the prior year. Total subscription pets increased 5% year-over-year to over 1,041,000 as of December 31st. The cost of paying veterinary invoices for the subscription business was $159.5 million, resulting in a value proposition of 70%, an improvement from 72.7% in the prior year period.
• Other Business Segment: Fourth quarter other business revenue was $109.5 million, up 5% year-over-year. Adjusted operating income for this segment was $0.8 million, with an adjusted operating margin of 0.8%, down from 2.4% last year. This margin was inclusive of a $0.9 million accounts receivable write down.

Guidance

• Revenue: For full year 2025, expect revenue in the range of $1.379 billion to $1.414 billion. Subscription revenue expected in the range of $961 million to $984 million.
• Adjusted Operating Income: Expected to be in the range of $120 million to $140 million for full year 2025.
• Pet Acquisition: Will gradually increase pet acquisition investment throughout 2025, aiming to approach the investment level of 2022. The mix of pricing vs. pet count contribution to revenue will shift as PAC dollars are deployed, with back half of 2025 expected to see elevation of PAC dollars.
• Free Cash Flow: Continue to target free cash flow generation, with a goal of 2.5% of revenue, having achieved 3% in 2024.

Risks

• Veterinary Industry Inflation: Impact on pricing and costs.
• Currency Headwinds: Approximately 1% headwind from Canadian currency on subscription revenue growth.
• Material Weaknesses: Progress made in remediating material weaknesses identified in 2023 audit, but ongoing risks exist.
• Goodwill Impairment: Goodwill impairment charge related to European businesses due to delayed launch and adjusted growth plans.

Question and Answer

Q: Please talk about the progression of subscriber growth throughout 2025.

A: Fawwad Qureshi mentioned that the company has the financial capacity from free cash flow to increase pet acquisition investment gradually. In 2024, revenue mix was ~60% pricing, ~40% pet count, and in 2025, as PAC dollars are deployed, the mix is expected to shift with back half of the year seeing more pet count contribution.

Q: Talk about vet leads and hospitals now at record numbers.

A: Margi Tooth stated that vet leads were up 30% year-over-year in Q4 2024. The goal is to deploy pet acquisition dollars to reinforce conversion, leveraging the high lead volume from territory partners.

Q: On subscription revenue guidance and split between ARPU and pet growth in 2025.

A: Fawwad Qureshi mentioned they haven't given specific guidance on the split down to granularity, but expect the mix dynamic to shift as PAC dollars are deployed, with historical being more pet count driven than pricing driven.

Q: Outlook for 2025 adjusted operating margins.

A: Fawwad Qureshi noted factors like inflation (expected to continue at 15% levels), fixed and variable expense leverage, and currency headwinds. Margi Tooth added the long-term goal is 15% margin, expecting to expand margin by over 300 basis points by end of 2025.

Q: On goodwill write-down and related markers.

A: Fawwad Qureshi explained the goodwill write-down was due to delayed launch of Trupanion Europe in Switzerland and Germany, and adjusted growth plans in Poland. The majority of remaining goodwill is related to the Aquarium acquisition, with Smart Paws write-down reducing goodwill to 0 and some remaining on PetExpert.